Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Simard

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
The EMBO Journal|May 3, 2000
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber typeH Wu, F J Naya, T A McKinsey, et al.
Journal of Child Neurology|September 1, 2007
Perspectives on clinical trials in spinal muscular atrophyKathryn J Swoboda, John T Kissel, Thomas O Crawford, et al.
Human Molecular Genetics|November 10, 2009
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E R Butchbach, Jasbir Singh, Margrét Thorsteinsdóttir, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal AntibodiesJeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory AdultsSamantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Nature Structural & Molecular Biology|December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiatorsXin Huang, Paul L Shaffer, Shawn Ayube, et al.
Frontiers in Cellular Neuroscience|April 18, 2022
Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and <i>p</i>CF3-diEPPKatrin Richter, Roger L Papke, Clare Stokes, et al.
Plos One|May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Plos One|September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
The EMBO Journal|May 3, 2000
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber typeH Wu, F J Naya, T A McKinsey, et al.
Journal of Child Neurology|September 1, 2007
Perspectives on clinical trials in spinal muscular atrophyKathryn J Swoboda, John T Kissel, Thomas O Crawford, et al.
Human Molecular Genetics|November 10, 2009
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E R Butchbach, Jasbir Singh, Margrét Thorsteinsdóttir, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2022
Modulation of Ligand-Gated Glycine Receptors Via Functional Monoclonal AntibodiesJeffrey R Simard, Klaus Michelsen, Yan Wang, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory AdultsSamantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Nature Structural & Molecular Biology|December 20, 2016
Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiatorsXin Huang, Paul L Shaffer, Shawn Ayube, et al.
Frontiers in Cellular Neuroscience|April 18, 2022
Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and <i>p</i>CF3-diEPPKatrin Richter, Roger L Papke, Clare Stokes, et al.
Plos One|May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Plos One|September 3, 2010
SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Thomas O Crawford, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Pageof 18